STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of PROLIA®</ ...

Cancer rates are rising among younger people aged under 50. Here’s what we know about the causes – and what the evidence says ...

Celltrion USA launches 2 denosumab biosimilars, Stoboclo and Osenvelt, enhancing treatment options for osteoporosis and ...

To investigate the clinical characteristics and risk factors associated with medication-related osteonecrosis of the jaw (MRONJ) and to introduce two metrics-equivalent dose (ED) and threshold dose ...

Fentanyl test strip use was associated with increased overdose risk reduction behaviors, but not with the risk for nonfatal overdose.

Some treatments for rheumatoid arthritis could increase cancer risk. One reason is because some cells in our immune system ...

Brain differences in children and teens who experiment with drugs early show up before they take their first puff or sip ...

Patients with chronic lymphocytic leukemia (CLL) or small lymphocytic leukemia (SLL) treated with venetoclax plus obinutuzumab experienced significantly higher rates of serious infections compared ...

Setting the regulatory bar too high for cutting-edge drugs and therapies prevents life-saving breakthroughs.

This review discusses the features of oligoarticular, polyarticular, systemic, and psoriatic JIA and enthesitis-related ...

Rapid sodium correction for hyponatremia could lead to the rare condition osmotic demyelination syndrome. Aaron Holley, MD, ...

The transfer of risk is the primary tenet of the insurance business, in which one party pays another to bear the costs of some potential expenses.